As an investor, we certainly value the trading liquidity that the established counterparties offer in our market, and we absolutely put a premium on those situations versus those where the deal is not going to trade to the same extent, we would expect cost of capital to be lower than for an instrument syndicated by an institution that hasn't invested as much in its trading platform.
